← Open Payments lookup

TAYLOR STINNETT: Open Payments

NPI 1619566619 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$306 in 14 payments from 8 companies in 2025. Trend: 2023 $461 · 2024 $606 · 2025 $306

Food & beverage: $306
CompanyPaymentsAmount
Novo Nordisk Inc3$89
ABBVIE INC.4$86
Amgen Inc.2$34
E.R. Squibb & Sons, L.L.C.1$25
Dexcom, Inc.1$23
AstraZeneca Pharmaceuticals LP1$20
Lilly USA, LLC1$15
Exact Sciences Corporation1$15

Products named: VRAYLAR, Ozempic, OTEZLA, Rybelsus, UBRELVY, ELIQUIS, Dexcom G6 Transmitter, AIRSUPRA.

Industry payments across NV — which companies pay providers there.